ImpediMed Ltd
ASX:IPD
ImpediMed Ltd
ASX:IPD
Price:
0.07 AUD
-1.41%
Market Closed
Updated:
Jun 8, 2024
ImpediMed Ltd
Gross Profit
|
ImpediMed Ltd
Gross Profit Peer Comparison
Comparables:
NTI
C
CYC
COH
OIL
EMV
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ImpediMed Ltd
ASX:IPD
|
Gross Profit
AU$9.1m
|
CAGR 3-Years
24%
|
CAGR 5-Years
31%
|
CAGR 10-Years
16%
|
|
|
Neurotech International Ltd
ASX:NTI
|
Gross Profit
AU$1.3m
|
CAGR 3-Years
192%
|
CAGR 5-Years
60%
|
CAGR 10-Years
N/A
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Gross Profit
AU$17.5m
|
CAGR 3-Years
18%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
|
Cochlear Ltd
ASX:COH
|
Gross Profit
AU$1.6B
|
CAGR 3-Years
19%
|
CAGR 5-Years
9%
|
CAGR 10-Years
12%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Gross Profit
AU$2.5m
|
CAGR 3-Years
223%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is ImpediMed Ltd's Gross Profit?
Gross Profit
9.1m
AUD
9.1m
AUD
Based on the financial report for Dec 31, 2023, ImpediMed Ltd's Gross Profit amounts to 9.1m AUD.
What is ImpediMed Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
16%
16%
Over the last year, the Gross Profit growth was -2%. The average annual Gross Profit growth rates for ImpediMed Ltd have been 24% over the past three years , 31% over the past five years , and 16% over the past ten years .
You don't have any saved screeners yet
